Literature DB >> 7222474

Scanning electron microscopic comparison between the thrombogenic properties of heparinized and non-heparinized vena cava catheters. A long-term study.

M Wenning, W W Höpker.   

Abstract

In an experimental comparative study on rabbits, the efficacy of the reduction of surface thrombus formation was investigated using heparinized central venous catheters compared with non-heparinized. Up to a central indwelling period of ten days, there was a reduction of the thrombus layer thickness on the heparinized catheters of 80% (with a trial duration of three days this was as much as 90%). The action of the stabilized surface heparin, which leads to a substantial thromboresistance, is complex in nature. 1) By intensified adsorption of plasma proteins in the early phase (proteins consist of antithrombin III, factor IX, X and XI), there is very much less thrombocyte adhesion and aggregation on the heparinized catheter surfaces. 2) The externally orientated negative net charge of the heparin shows a similar effect. 3) If there is thrombocyte adhesion despite this, further heparin effects become more prominent. Thus the release of ThF 3 and ADP, which leads to aggregation, is markedly inhibited. On the other hand, this leads to easier dissolution of already aggregated thrombocytes and on the other to a reduction of the catalytic thrombocyte surface for the plasma clotting factors. 4) This effect is supported by the increased adsorption of antithrombin III onto the control surface. 5) Finally there is also an inhibitory effect of heparin on the activated Stuart-Prower factor. Local thrombosis on the venous catheter surface can thus be effectively reduced by local therapy, without greater risks for the intensive care patient.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7222474     DOI: 10.1007/bf00437597

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histol        ISSN: 0340-1227


  16 in total

1.  Bio-electric phenomena as an etiologic factor in intravascular thrombosis.

Authors:  P N SAWYER; J W PATE
Journal:  Am J Physiol       Date:  1953-10

2.  Determination of platelet adhesion to polyethylene and heparinized surfaces with the aid of bioluminescence and 51chromium labelled platelets.

Authors:  R Larsson; A Rosengren; P Olsson
Journal:  Thromb Res       Date:  1977-10       Impact factor: 3.944

3.  [Subclavian vein catheter in surgical intensive therapy].

Authors:  J Schöche
Journal:  Zentralbl Chir       Date:  1973-02-23       Impact factor: 0.942

4.  Inhibited platelet adhesion: a non-thrombogenic characteristic of a heparin-coated surface.

Authors:  H Lagergren; P Olsson; J Swedenborg
Journal:  Surgery       Date:  1974-05       Impact factor: 3.982

5.  Heparinized vascular cathers: a clinical trial.

Authors:  P Eldh; B Jacobsson
Journal:  Radiology       Date:  1974-05       Impact factor: 11.105

6.  [The use of the subclavian catheter in a medical intensive care unit (author's transl)].

Authors:  H W Pilgerstorfer; G Finkenstedt; G Kleinberger; R Kotzaurek; H Pall; M Pichler; G Raberger; S Szeless
Journal:  Wien Klin Wochenschr       Date:  1973-12-14       Impact factor: 1.704

7.  [Puncture of the subclavian vein and its complications from the pathological and anatomical viewpoint].

Authors:  G Scholz; K R Loewe
Journal:  Med Welt       Date:  1969-10-11

8.  Prevention of platelet adhesion and aggregation by a glutardialdehyde-stabilized heparin surface.

Authors:  P Olsson; H Lagergren; R Larsson; K Rådegran
Journal:  Thromb Haemost       Date:  1977-04-30       Impact factor: 5.249

9.  Thrombogenic properties of heparinised vascular catheters.

Authors:  B Jacobsson; D Schlossman
Journal:  Acta Radiol Diagn (Stockh)       Date:  1973-09

10.  The molecular mechanisms of heparin action: II. Separation of functionally different heparins by affinity chromatography.

Authors:  F J Walker; C T Esmon
Journal:  Thromb Res       Date:  1979-01       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.